PL EN


Preferences help
enabled [disable] Abstract
Number of results
2015 | 62 | 3 | 559-562
Article title

Screening for genetic mutations in LDLR gene with familial hypercholesterolemia patients in the Saudi population

Content
Title variants
Languages of publication
EN
Abstracts
EN
Familial hypercholesterolemia (FH) is caused by genetic defects involving the low density lipoprotein-receptor (LDL-R), predisposing affected people to premature atherosclerotic cardiovascular disease and death. The aim of the present study was to assess certain exons in the LDLR gene mutation detection analysis affecting in the Saudi population with FH. This case-control study was carried out with 200 subjects; 100 were FH cases and 100 were healthy controls. Five mL of venous blood samples were collected from all the subjects and used for biochemical and genetic analysis. DNA was extracted from 2 mL of the EDTA samples, and precise primers were designed for LDL-R gene which includes Exon 3, 4 and 8. PCR was followed by DNA sequencing. In our study, we found 25 mutations in cases in Exon-3 and 2 mutations in controls, however, we have found only 5 mutations in exon 4 and none of the mutations were identified in exon 8. We conclude that screening of FH among Saudi population is very important to identify individuals who are prone to develop the disease.
Publisher

Year
Volume
62
Issue
3
Pages
559-562
Physical description
Dates
published
2015
received
2015-03-23
revised
2015-06-28
accepted
2015-07-31
(unknown)
2015-09-08
Contributors
  • Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, King Saud University, P.O. Box 10219, Riyadh 11433, Kingdom of Saudi Arabia
author
  • Department of Cardiac Sciences, College of medicine, King Fahad Cardiac Center, King Saud University, P.O. Box 7805 (92), Riyadh 11472, Kingdom of Saudi Arabia
  • Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, King Saud University, P.O. Box 10219, Riyadh 11433, Kingdom of Saudi Arabia
  • Stem Cell Units, Anatomy Department, College of Medicine, King Khalid University Hospital, Riyadh, Kingdom of Saudi Arabia
author
  • Stem Cell Units, Anatomy Department, College of Medicine, King Khalid University Hospital, Riyadh, Kingdom of Saudi Arabia
  • Preparatory Year-Saudi Electronic University, Riyadh, Saudi Arabia
author
  • Department of Pathology, College of medicine, King Saud University, King Khalid University Hospital, P.O. Box 66533, Riyadh 11586, Kingdom of Saudi Arabia
author
  • Department of Pediatrics, King Khalid University Hospital and College of medicine, King Saud University, P.O. Box 2925, Riyadh 11461, Kingdom of Saudi Arabia
author
  • Department of Pathology & Laboratory Medicine, King Fahad National Guard Hospital, Riyadh, Saudi Arabia
  • College of Medicine King Saud Bin Abdulaziz University for Health Sciences, P.O. Box 22490, Riyadh 11426, Saudi Arabia
author
  • Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, King Saud University, P.O. Box 10219, Riyadh 11433, Kingdom of Saudi Arabia
References
  • Komarova TY, Golovina AS, Grudinina NA, Zakharova FM, Korneva VA, Lipovetsky BM, Serebrenitskaya MP, Konstantinov VO, Vasilyev VB, Mandelshtam MY (2013) New mutations in low-density lipoprotein receptor gene in familial hypercholesterolemia patients from Petrozavodsk. Genetika 49: 773-777.
  • Alharbi KK, Kashour TS, Al-Hussaini W, Al-Nbaheen MS, Mohamed S, Hasanato RM, Tamimi W, Al-Naami MY, Khan IA (2013) Association of angiotensin converting enzyme gene insertion/deletion polymorphism and familial hypercholesterolemia in the Saudi population. Lipids Health Dis 12: 177.
  • Mavroidis N, Traeger-Synodinos J, Kanavakis E, Drogari E, Matsaniotis N, Humphries SE, Day IN, Kattamis C (1997) A high incidence of mutation in exon 6 of the low-density lipoprotein receptor gene in Greek familial hypercholesterolemia patients, including a novel mutation. Hum Mutat 9: 274-276.
  • Robinson JG (2013) Management of familial hypercholesterolemia: a review of the recommendations from the National Lipid Association Expert Panel on Familial Hypercholesterolemia. J Manag Care Pharm 19: 139-149.
  • Lye SH, Chahil JK, Bagali P, Alex L, Vadivelu J, Ahmad WA, Chan SP, Thong MK, Zain SM, Mohamed R (2013) Genetic polymorphisms in LDLR, APOB, PCSK9 and other lipid related genes associated with familial hypercholesterolemia in Malaysia. PLoS One 8: e60729.
  • Hobbs HH, Brown MS, Russell DW, Davignon J, Goldstein JL (1987) Deletion in the gene for the low-density-lipoprotein receptor in a majority of French Canadians with familial hypercholesterolemia. New Engl J Med 317: 734-737.
  • Moorjan S, Roy M, Gagne C, et al (1989) Homozygous familial hypercholesterolemia among French Canadians in Quebec Province. Arteriosclerosis 9: 211-16.
  • Yuan G, Wang J, Hegele RA (2006) Heterozygous familial hypercholesterolemia: an underrecognized cause of early cardiovascular disease. CMAJ 174: 1124-1129.
  • Zeegers MP, van Poppel F, Vlietinck R, Spruijt L, Ostrer H (2004) Founder mutations among the Dutch. Eur J Hum Genet 12: 591-600.
  • Alex L, Chahil JK, Lye SH, Bagali P, Ler LW (2012) Differences in allele frequencies of autosomal dominant hypercholesterolemia SNPs in the Malaysian population. J Hum Genet 57: 358-362.
  • Hopkins PN, Toth PP, Ballantyne CM, Rader DJ (2011) Familial Hypercholesterolemias: prevalence, genetics, diagnosis and screening recommendations from the National Lipid Association Expert Panel on Familial Hypercholesterolemia. J Clin Lipidol 5: S9-S17.
  • Garcia CK, Mues G, Liao Y, Hyatt T, Patil N, Cohen JC, Hobbs HH (2001) Sequence diversity in genes of lipid metabolism. Genome Res 11: 1043-1052.
  • Ng MC, Wang Y, So WY, Cheng S, Visvikis S, Zee RY, Fernandez-Cruz A, Lindpaintner K, Chan JC (2004) Ethnic differences in the linkage disequilibrium and distribution of single-nucleotide polymorphisms in 35 candidate genes for cardiovascular diseases. Genomics 83: 559-565.
  • Benn M, Watts GF, Tybjaerg-Hansen A, Nordestgaard BG (2012) Familial hypercholesterolemia in the Danish general population: prevalence, coronary artery disease, and cholesterol-lowering medication. Clin Endocrinol Metab 97: 3956-3964.
Document Type
Publication order reference
Identifiers
YADDA identifier
bwmeta1.element.bwnjournal-article-abpv62p559kz
JavaScript is turned off in your web browser. Turn it on to take full advantage of this site, then refresh the page.